From July 17, 2023 to September 30, 2023, the company has repurchased 5,958,154 shares, representing 0.75% for CNY 122.88 million. With this, the company has completed the repurchase of 5,958,154 shares, representing 0.75% for CNY 122.88 million under the buyback announced on July 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.49 CNY | -0.29% | -0.33% | +23.66% |
May. 24 | Jafron Biomedical Co.,Ltd. Announces Final Dividend on A Shares for 2023, Payable on 31 May 2024 | CI |
Apr. 26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.66% | 2.94B | |
-2.34% | 187B | |
+0.92% | 110B | |
-1.77% | 69.54B | |
+14.21% | 46.37B | |
-6.06% | 46.05B | |
+7.97% | 42.54B | |
+19.03% | 30.72B | |
+17.70% | 25.62B | |
-7.25% | 23.32B |
- Stock Market
- Equities
- 300529 Stock
- News Jafron Biomedical Co.,Ltd.
- Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.